HIADX
Price
$24.93
Change
+$0.04 (+0.16%)
Updated
Jun 2 closing price
Net Assets
3.49B
RMFCX
Price
$62.47
Change
+$0.39 (+0.63%)
Updated
Jun 2 closing price
Net Assets
114.65B
Interact to see
Advertisement

HIADX vs RMFCX

Header iconHIADX vs RMFCX Comparison
Open Charts HIADX vs RMFCXBanner chart's image
HIADX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
HIADX vs. RMFCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIADX is a Hold and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 115B vs. HIADX (3.49B). HIADX (1.24) and RMFCX (1.19) have matching dividends . HIADX was incepted earlier than RMFCX: HIADX (32 years) vs RMFCX (24 years). RMFCX (0.91) is less costly to investors than HIADX (0.66). HIADX is a more actively managed with annual turnover of: 62.00 vs. RMFCX (30.00). HIADX has a lower initial minimum investment than RMFCX: HIADX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 10.10 vs. HIADX (5.57). RMFCX return over 5 years is better than : 33.85 vs. HIADX (2.97).
HIADXRMFCXHIADX / RMFCX
Total Expense Ratio0.660.9173%
Annual Report Gross Expense Ratio0.660.9173%
Fund Existence32 years24 years-
Gain YTD8.8335.845151%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.49B115B3%
Annual Yield % from dividends1.241.19104%
Returns for 1 year5.5710.1055%
Returns for 3 years13.8034.6540%
Returns for 5 years2.9733.859%
Returns for 10 years28.6691.4631%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AXGN39.460.74
+1.91%
Axogen
XTNT0.47N/A
+0.61%
Xtant Medical Holdings
GBFH29.490.08
+0.27%
Gbank Financial Holdings Inc
KBONU10.270.01
+0.10%
Karbon Capital Partners Corp
GMED78.25-1.53
-1.92%
Globus Medical